A
Acceleron Pharma Inc 128 Sidney Street Category: Biotechnology Products and Services |
Company representatives
Kevin Mc Laughlin, Chief Financial Officer
Kenneth Attie, Vice President
Steven Ertel, Vice President
Products and Services
- Human Biotechnology
- Mit Biotechnology
- Bolder Biotechnology
- Red Biotechnology
- Sid Martin Biotechnology
Location Type
Single Location
Employees
1 to 4
State of incorporation
Information not found
SIC code
873126 (Biotechnology Products & Services)
NAICS code
541711 (Research & Development in Biotechnology)